Advertisement

IBD Patient’s Guide

  • Hubert ZatorskiEmail author
Chapter
  • 739 Downloads

Abstract

Understanding inflammatory bowel disease (IBD) and its treatment poses a great challenge for both the patient and the doctor. In this chapter, diet and lifestyle, psychological aspects and treatment of IBD are discussed. The impact of diet, smoking and alcohol drinking on IBD is also presented. Due to the fact that patients with IBD more often suffer from depression and anxiety, standard treatments for these conditions are also described. Moreover, differences in bacterial content in gastrointestinal (GI) tract between IBD patients and healthy individuals are characterized. Finally, information about cooperation between the patient and the doctor is given.

Keywords

Diet Lifestyle Microbiota Obesity Psychological aspects Smoking 

Abbreviations

AIEC

Adherent-invasive E. coli

CD

Crohn’s disease

FODMAP

Fermentable Oligo-, Di-, Monosaccharides and Polyols

IBD

Inflammatory Bowel Disease

NSAIDs

Non-steroidal anti-inflammatory drugs

QoL

Quality of Life

SNRI

Serotonin Norepinephrine Reuptake Inhibitors

SSRIs

Selective Serotonin Reuptake Inhibitors

UC

Ulcerative colitis

References

  1. 1.
    Carbonnel F, Jantchou P, Monnet E, Cosnes J (2009) Environmental risk factors in Crohn’s disease and ulcerative colitis: an update. Gastroenterol Clin Biol 33(Suppl 3):S145–S157PubMedCrossRefGoogle Scholar
  2. 2.
    Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G et al (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142(1):46–54CrossRefGoogle Scholar
  3. 3.
    Bernstein CN (2010) New insights into IBD epidemiology: Are there any lessons for treatment? Dig Dis 28(3):406–410PubMedCrossRefGoogle Scholar
  4. 4.
    Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ et al (2007) The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 5(12):1424–1429PubMedCrossRefGoogle Scholar
  5. 5.
    Hou JK, Abraham B, El-Serag H (2011) Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol 106(4):563–573CrossRefGoogle Scholar
  6. 6.
    Dixon LJ, Kabi A, Nickerson KP, McDonald C (2015) Combinatorial effects of diet and genetics on inflammatory bowel disease pathogenesis. Inflamm Bowel Dis 21(4):912–922PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Russel MG, Engels LG, Muris JW, Limonard CB, Volovics A, Brummer RJ et al (1998) Modern life’ in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol 10(3):243–249PubMedCrossRefGoogle Scholar
  8. 8.
    Sakamoto N, Kono S, Wakai K, Fukuda Y, Satomi M, Shimoyama T, et al. (2005) Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis 11(2)PubMedCrossRefGoogle Scholar
  9. 9.
    Reif S, Klein I, Lubin F, Farbstein M, Hallak A, Gilat T (1997) Pre-illness dietary factors in inflammatory bowel disease. Gut 40(6):754–760PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Fuchs CS et al (2014) Long-term Intake of dietary fat and risk of ulcerative colitis and Crohn’s disease. Gut 63(5):776–784CrossRefGoogle Scholar
  11. 11.
    Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Korzenik JR et al (2013) A prospective study of long-term intake of dietary fiber and risk of Crohn’s disease and ulcerative colitis. Gastroenterology 145(5):970–977PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Owczarek D, Rodacki T, Domagala-Rodacka R, Cibor D, Mach T (2016) Diet and nutritional factors in inflammatory bowel diseases. World J Gastroenterol 22(3):895–905PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Cohen AB, Lee D, Long MD et al (2013) Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Dig Dis Sci 58(5):1322–1328. doi: 10.1007/s10620-012-2373-3PubMedCrossRefGoogle Scholar
  14. 14.
    Herfarth HH, Martin CF, Sandler RS, Kappelman MD, Long MD (2014) Prevalence of a gluten free diet and improvement of clinical symptoms in patients with inflammatory bowel diseases. Inflamm Bowel Dis 20(7):1194–1197PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Marlow G, Ellett S, Ferguson IR, Zhu S, Karunasinghe N, Jesuthasan AC et al (2013) Transcriptomics to study the effect of a Mediterranean-inspired diet on inflammation in Crohn’s disease patients. Human Genomics 7(1):1–9CrossRefGoogle Scholar
  16. 16.
    Cohen SA, Gold BD, Oliva S, Lewis J, Stallworth A, Koch B, et al. Clinical and mucosal improvement with specific carbohydrate diet in pediatric crohn disease. J Pediatr Gastroenterol Nutrition 59(4)PubMedCrossRefGoogle Scholar
  17. 17.
    Gearry RB, Irving PM, Barrett JS, Nathan DM, Shepherd SJ, Gibson PR (2009) Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease—A pilot study. J Crohn’s Colitis 3(1):8–14CrossRefGoogle Scholar
  18. 18.
    Cosnes J (2010) Smoking, physical activity, nutrition and lifestyle: environmental factors and their impact on IBD. Dig Dis 28(3):411–417PubMedCrossRefGoogle Scholar
  19. 19.
    Lakatos PL, Szamosi T, Lakatos L (2007) Smoking in inflammatory bowel diseases: good, bad or ugly? World J Gastroenterol 13(46):6134–6139PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Loftus EV Jr, Sandborn WJ, Tremaine WJ, Mahoney DW, Zinsmeister AR, Offord KP et al (1996) Primary sclerosing cholangitis is associated with nonsmoking: a case- control study. Gastroenterology 110(5):1496–1502PubMedCrossRefGoogle Scholar
  21. 21.
    Cosnes J, Carbonnel F, Carrat F, Beaugerie L, Cattan S, Gendre J (1999) Effects of current and former cigarette smoking on the clinical course of Crohn’s disease. Aliment Pharmacol Ther 13(11):1403–1411PubMedCrossRefGoogle Scholar
  22. 22.
    Russel MGVM, Volovics A, Schoon EJ, van Wijlick EHJ, Logan RF, Shivananda S, et al (1998) Inflammatory bowel disease: is there any relation between smoking status and disease presentation? Inflamm Bowel Dis 4(3)CrossRefGoogle Scholar
  23. 23.
    Persson PG, Ahlbom A, Hellers G (1990) Inflammatory bowel disease and tobacco smoke—A case-control study. Gut 31(12):1377–1381PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Cosnes J (2004) Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol 18(3):481–496PubMedCrossRefGoogle Scholar
  25. 25.
    Motley RJ, Rhodes J, Ford GA, Wilkinson SP, Chesner IM, Asquith P et al (1987) Time relationships between cessation of smoking and onset of ulcerative colitis. Digestion 37(2):125–127PubMedCrossRefGoogle Scholar
  26. 26.
    Beaugerie L, Massot N, Carbonnel F, Cattan S, Gendre JP, Cosnes J (2001) Impact of cessation of smoking on the course of ulcerative colitis. Am J Gastroenterol 96(7):2113–2116PubMedCrossRefGoogle Scholar
  27. 27.
    Cosnes J, Beaugerie L, Carbonnel F, Gendre J (2001) Smoking cessation and the course of Crohn’s disease: an intervention study. Gastroenterology 120(5):1093–1099CrossRefGoogle Scholar
  28. 28.
    El-Tawil AM (2013) Epidemiology and inflammatory bowel diseases. World J Gastroenterol 19(10):1505–1507PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Nakarnura Y, Labarthe DR (1994) A case-control study of ulcerative colitis with relation to smoking habits and alcohol consumption in Japan. Am J Epidemiol 140(10):902–911CrossRefGoogle Scholar
  30. 30.
    Jiang L, Xia B, Li J, Ye M, Deng C, Ding Y, et al (2007) Risk factors for ulcerative colitis in a chinese population: an age-matched and sex-matched case-control study. J Clin Gastroenterol 41(3)PubMedCrossRefGoogle Scholar
  31. 31.
    D’Inca R, Varnier M, Mestriner C, Martines D, D’Odorico A, Sturniolo GC (1999) Effect of moderate exercise on Crohn’s disease patients in remission. Ital J Gastroenterol Hepatol 31(3):205–210PubMedGoogle Scholar
  32. 32.
    Loudon CP, Corroll V, Butcher J, Rawsthorne P, Bernstein CN (1999) The effects of physical exercise on patients with Crohn’s disease. Am J Gastroenterol 94(3):697–703PubMedCrossRefGoogle Scholar
  33. 33.
    Ng V, Millard W, Lebrun C, Howard J (2007) Low-intensity exercise improves quality of life in patients with Crohn’s disease. Clin J Sport Med 17(5):384–388PubMedGoogle Scholar
  34. 34.
    Wiroth JB, Filippi J, Schneider SM, Al-Jaouni R, Horvais N, Gavarry O, et al (2005) Muscle Performance in patients with Crohn’s disease in clinical remission. Inflammatory Bowel Dis 11(3)PubMedCrossRefGoogle Scholar
  35. 35.
    Lee N, Radford-Smith G, Taaffe DR (2005) Bone loss in Crohn’s disease: exercise as a potential countermeasure. Inflamm Bowel Dis 11(12):1108–1118PubMedCrossRefGoogle Scholar
  36. 36.
    Robinson RJ, Krzywicki T, Almond L, Al–Azzawi F, Abrams K, Iqbal SJ et al (1998) Effect of a low-impact exercise program on bone mineral density in Crohn’s disease: a randomized controlled trial. Gastroenterology 115(1):36–41PubMedCrossRefGoogle Scholar
  37. 37.
    Blain A, Cattan S, Beaugerie L, Carbonnel F, Gendre JP, Cosnes J (2002) Crohn’s disease clinical course and severity in obese patients. Clin Nutr 21(1):51–57PubMedCrossRefGoogle Scholar
  38. 38.
    Steed H, Walsh S, Reynolds N (2009) A brief report of the epidemiology of obesity in the inflammatory bowel disease population of tayside, Scotland. Obes Facts 2(6):370–372PubMedCrossRefGoogle Scholar
  39. 39.
    Hass DJ, Brensinger CM, Lewis JD, Lichtenstein GR () The impact of increased body mass index on the clinical course of Crohn’s disease. Clin Gastroenterol Hepatol 4(4):482–488PubMedCrossRefGoogle Scholar
  40. 40.
    Berg RD (1996) The indigenous gastrointestinal microflora. Trends Microbiol 4(11):430–435PubMedCrossRefGoogle Scholar
  41. 41.
    Zatorski H, Fichna J (2014) What is the future of the gut microbiota-related treatment? Toward modulation of microbiota in preventive and therapeutic medicine. Front Med (Lausanne) 1:19Google Scholar
  42. 42.
    Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M et al (2012) Human gut microbiome viewed across age and geography. Nature 486(7402):222–227PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR et al (2011) Enterotypes of the human gut microbiome. Nature 473(7346):174–180PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    Salonen A, Salojärvi J, Lahti L, de Vos WM (2012) The adult intestinal core microbiota is determined by analysis depth and health status. Clin Microbiol Infect 18:16–20PubMedCrossRefGoogle Scholar
  45. 45.
    Marques TM, Cryan JF, Shanahan F, Fitzgerald GF, Ross RP, Dinan TG et al (2014) Gut microbiota modulation and implications for host health: dietary strategies to influence the gut–brain axis. Innovative Food Sci Emerg Technol 22:239–247CrossRefGoogle Scholar
  46. 46.
    Buttó LF, Haller D (2016) Dysbiosis in intestinal inflammation: Cause or consequence. Int J Med Microbiol 306(5):302–309PubMedCrossRefGoogle Scholar
  47. 47.
    Schippa S, Conte MP (2014) Dysbiotic events in gut microbiota: impact on human health. Nutrients 6(12):5786–5805PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Øyri SF, Müzes G, Sipos F (2015) Dysbiotic gut microbiome: a key element of Crohn’s disease. Comp Immunol Microbiol Infect Dis 43:36–49PubMedCrossRefGoogle Scholar
  49. 49.
    Takaishi H, Matsuki T, Nakazawa A, Takada T, Kado S, Asahara T et al (2008) Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. Int J Med Microbiol 298(5):463–472PubMedCrossRefGoogle Scholar
  50. 50.
    Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, et al (2009) Low counts of Faecalibacterium prausnitziiin colitis microbiota. Inflamm Bowel Dis 15(8)PubMedCrossRefGoogle Scholar
  51. 51.
    Ohkusa T, Koido S (2015) Intestinal microbiota and ulcerative colitis. J Infect Chemother 21(11):761–768PubMedCrossRefGoogle Scholar
  52. 52.
    Burke DA, Axon AT (1988) Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea. BMJ 297(6641):102–104PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Ohkusa T, Okayasu I, Ogihara T, Morita K, Ogawa M, Sato N (2003) Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut 52(1):79–83PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Bernstein CN, Singh S, Graff LA, Walker JR, Miller N, Cheang M (2010) A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol 105(9):1994–2002PubMedCrossRefGoogle Scholar
  55. 55.
    Filipović BR, Filipović BF (2014) Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease. World J Gastroenterol 20(13):3552–3563PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Filipović BR, Filipović BF, Kerkez M, Milinić N, Randelovć T (2007) Depression and anxiety levels in therapy-naive patients with inflammatory bowel disease and cancer of the colon. World J Gastroenterol 13(3):438–443PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Goodhand JR, Greig FIS, Koodun Y, McDermott A, Wahed M, Langmead L, et al (2012) Do Antidepressants influence the disease course in inflammatory bowel disease? A retrospective case-matched observational study. Inflamm Bowel Dis 18(7)PubMedCrossRefGoogle Scholar
  58. 58.
    Sobczak M, Fabisiak A, Murawska N, Wesolowska E, Wierzbicka P, Wlazlowski M et al (2014) Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases. Pharmacol Rep 66(5):766–775PubMedCrossRefGoogle Scholar
  59. 59.
    Sobczak M, Wlazłowski M, Zatorski H, Sałaga M, Fichna J (2014) Current overview of colitis-associated colorectal cancer. Central Eur J Biol 9(11):1022–1029Google Scholar
  60. 60.
    Husain A, Triadafilopoulos G (2004) Communicating with patients with inflammatory bowel disease. Inflamm Bowel Dis 10(4)PubMedCrossRefGoogle Scholar
  61. 61.
    Leshem RN (2003) Inflammatory bowel disease support groups: a primer for gastroenterology nurses. Gastroenterol Nurs 26(6)PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 2.5 International License (http://creativecommons.org/licenses/by-nc/2.5/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

The images or other third party material in this chapter are included in the chapter's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the chapter's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

Authors and Affiliations

  1. 1.Faculty of Medicine, Department of BiochemistryMedical University of LodzLodzPoland

Personalised recommendations